Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker

Far Eastern Memorial Hospital

Overview

This study investigates whether the amount of circulating plasma DNA can be used as a response marker for anti-cancer treatment in treating gross tumors.

Study Type

OBSERVATIONAL

Conditions

Head and Neck Cancer Esophageal Cancer

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Head and neck cancers * Esophageal cancer * Undergoing anti-cancer treatments Exclusion Criteria: * No distant metastasis

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.